At Saince, we build the technological foundation that empowers providers to focus entirely on their patients. By seamlessly integrating artificial intelligence, cloud-native infrastructure, and deep system interoperability, we are eliminating inefficiencies and bringing clinical information, radiology, and hospital management into the modern era. We are not just a service provider—we are a high-tech innovation engine for the healthcare industry.

USA: 5490 McGinnis Village Place, Suite 116, Alpharetta, GA 30005.
+1 888 472 4623 | sales@saince.com
INDIA: Corporate Address: #6-3-1090, Ground Floor, Block B, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad, Telangana 500082.
Registered Address: #202, Shatabdi Residency, Ramnagargundu, Hyderabad, Telangana 500044.
+91 40 6728 5555 | sales@saince.in
Contact Us
Address 5490 McGinnis Village Place, Suite 116, Alpharetta, GA 30005.
Follow Us

Clinical documentation, imaging and intelligence solutions.

Blog Details

Blogs
Why radiologists should consider earlier follow-up imaging for Lung-RADS cases August 22, 2021

Why radiologists should consider earlier follow-up imaging for Lung-RADS cases

New evidence out of Stanford suggests providers may want to consider ordering follow-up CTs for probably benign nodules earlier than is currently suggested. Doing so reduced mortality rates and prevented more deaths, among other health benefits. 

Utilizing five month follow-up for Lung-RADS 3 reduced mortality by 0.08% in men and 0.05% among women. Earlier care also averted deaths (36 male vs. 27 female), yielded more screen-detected cases (13 vs. 7, respectively) and lowered the number of combined low-dose CTs per 1 million people.

Further comparative cost-effectiveness analysis using trial data or simulated population are required to evaluate the impact of alternative diagnostic follow-up on cost-effectiveness analysis.

Read more : https://www.healthimaging.com/topics/oncology/radiologists-lung-rads-early-follow-imaging